为什么要打造属于我国自己的人工智能底座？如何突破靶向药依赖进口的困境？大数据和人工智能如何 治理城市、改善民生？10月16日，在中央戏剧学院昌平校区，"社会主义是干出来的 新时代是奋斗出来 的"首都产业一线科技人才走进高校系列宣讲举行，来自智能建造、生物制药以及新一代信息技术三个 领域的首都产业一线科技人才现场分享自己在科研领域的"破冰"经历，坚定同学们的理想信念。 科技人才分享创业中的攻坚克难 在郑宇看来，能让他坚守在科研一线的原因有三点：对城市计算的科技信念，坚韧的意志，社会责任和 家国情怀。从业近二十年，他强烈地感受到，个人的发展跟祖国息息相关、紧密相连，只有祖国强大才 能提供优质的工作环境、完善的基础设施、充沛的科研资源，从而培育出更多优秀的个体。他告诉同学 们，个体也应以祖国的强大和发展为事业目标，顺应时代发展，乘势而行。 和王绍兰一样，其他两位科技人才也在创业中遇到过瓶颈和困境。首药控股（北京）股份有限公司副总 经理孙颖慧带来《为生命续航：中国创新药的自主研发》的宣讲。她讲到，经过十几年的历程，研制出 的靶向药将过去"无药可治"的困境，变成了"长期可控"的希望。 "听完王绍兰老师的分享，我深受触动 ...

Group 1 - The core viewpoint of the article highlights the recent stock performance of CSPC Pharmaceutical Group, which saw a decline of 2.03% to HKD 10.15 per share, with a trading volume of HKD 374 million [1] - CSPC Pharmaceutical Group is a Hong Kong-listed pharmaceutical company primarily engaged in the production of finished drugs and active pharmaceutical ingredients, focusing on innovative drugs as its core development strategy [1] - The company has a strong product portfolio in therapeutic areas such as neurological diseases, oncology, anti-infection, and cardiovascular diseases, supported by an international R&D team [1] Group 2 - As of the first quarter of 2025, CSPC Pharmaceutical Group reported total revenue of HKD 7.015 billion and a net profit of HKD 1.478 billion [2]

Group 1 - The core viewpoint of the article highlights the performance and strategic focus of CSPC Pharmaceutical Group Limited, emphasizing its strong product portfolio in various therapeutic areas and its innovative drug development strategy [1][2][3] Group 2 - As of the first quarter of 2025, CSPC Pharmaceutical Group reported total revenue of 7.015 billion yuan and a net profit of 1.478 billion yuan [2] - The company’s stock price increased by 2.07% to 9.86 yuan per share, with a trading volume of 0.852 billion yuan as of 11:40 AM on August 5 [1]

Group 1: Economic Growth Indicators - Jiangsu province's average daily truck flow at highway exits increased by 21,000 vehicles compared to the first quarter, indicating robust economic activity [2][3] - Industrial electricity consumption in Jiangsu grew by 3.1% year-on-year in the first four months, reflecting economic resilience and a positive trend [4] - The province's machinery and electrical products export reached 848.01 billion yuan, a year-on-year increase of 11.1%, accounting for 68.9% of total exports [5] Group 2: Logistics and Transportation Efficiency - The digital freight platform "Yunmanman" improved logistics efficiency, with a 22.6% year-on-year increase in order fulfillment and a 28.8% rise in active shippers [2] - The average monthly truck flow on the Hu-Ning Expressway increased by approximately 21.06% in April compared to the first quarter, showcasing the active logistics network [3] Group 3: Major Projects and Investments - A total of 500 major provincial projects in Jiangsu completed investments of 231.9 billion yuan, achieving a completion rate of 35.5% by the end of April [7] - The province's financial institutions have provided 556.3 billion yuan in financing for major projects, with an increase of 81.2 billion yuan since the beginning of the year [8] Group 4: Sector-Specific Developments - The biopharmaceutical sector saw a significant electricity consumption increase of 20.4%, indicating strong growth potential [4] - The automotive industry experienced a 51.3% surge in production of new energy vehicles in Changzhou during the first quarter, driving electricity consumption in the sector [4][6]